Description
About Precision NanoSystems
Precision NanoSystems Inc. (PNI) creates innovative solutions for the discovery, development and manufacture of novel nanoparticles for use as medicines and in medical research. PNI’s proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology.
Exceptional Versatility
Example Application
Nucleic Acid Lipid Nanoparticles (LNP)
Rare genetic diseases
mRNA protein replacement
mRNA vaccines
Gene and cell therapy
Liposomes
Vaccine adjuvants
Antimicrobials
Cancer chemotherapy
Diabetes combination therapy
Polymer NPs
Cancer chemotherapy
Targeted protein delivery
Controlled release/biodistribution
Immuno-oncology
Emulsions
Cancer chemotherapy
Drug formulation
Controlled release/biodistribution
Organic/ inorganic NPs
Theranostics
Imaging
Carrier Materials
Nucleic Acid Lipid Nanoparticles (LNP)
Rare genetic diseases
mRNA protein replacement
mRNA vaccines
Gene and cell therapy
Liposomes
Vaccine adjuvants
Antimicrobials
Cancer chemotherapy
Diabetes combination therapy
Polymer NPs
Cancer chemotherapy
Targeted protein delivery
Controlled release/biodistribution
Immuno-oncology
Emulsions
Cancer chemotherapy
Drug formulation
Controlled release/biodistribution
Organic/ inorganic NPs
Theranostics
Imaging
